TG Therapeutics Publishes Post-Hoc Pooled Analysis Of Its Phase 3 ULTIMATE I, II Trials Of BRIUMVI To Treat Relapsing Forms Of Multiple Sclerosis

뉴스 본문을 불러오고 있어요.

TG Therapeutics Publishes Post-Hoc Pooled Analysis Of Its Phase 3 ULTIMATE I, II Trials Of BRIUMVI To Treat Relapsing Forms Of Multiple Sclerosis | 웨이프 WAPE

TG Therapeutics Publishes Post-Hoc Pooled Analysis Of Its Phase 3 ULTIMATE I, II Trials Of BRIUMVI To Treat Relapsing Forms Of Multiple Sclerosis

기사 요약

관련 종목

댓글 —